Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics PRESS RELEASE Algenex and Biokit renew licensing agreement for insect-based production of human in vitro diagnostics Madrid and Barcelona (Spain) 18 November, 2021 – Algenex SL, a biotech company...

Algenex enters biocomponents market to provide mammalian-free production of cost efficient high-quality proteins and peptides PRESS RELEASE Algenex enters biocomponents market to provide mammalian-free production of cost efficient high-quality proteins and peptides Proven technology poised to accelerate growth of emerging...

Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease PRESS RELEASE Algenex and FATRO announce positive CVMP opinion for CrisBio-based vaccine for Rabbit Viral Haemorrhagic Disease Madrid (Spain) and Bologna (Italy), June 21, 2021 – Algenex SL, a...